
September 2025 Recall: Topics on Epilepsy
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
The September 2025 Recall replay highlights four previously released episodes focused on epilepsy. Dr. Halley Alexander begins the series with Dr. Juan Luis Alcala-Zermeno, discussing outcomes of epilepsy surgery in patients with tonic-clonic seizures. She then speaks with Dr. Samuel W. Terman about patients’ perceived seizure risk, seizure risk tolerance, and approaches to risk counseling. In the third episode, Dr. Alexander is joined by Dr. Vineet Punia to explore factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures. The replay concludes with Dr. Katie Krulisky’s conversation with Dr. Leah Blank on how outpatient follow-up impacts readmission rates in older adults with epilepsy or seizures
Podcast links:
The Effect of Epilepsy Surgery on Tonic–Clonic Seizures
Patient Perspectives on Antiseizure Medication Discontinuation
Understanding Acute Symptomatic Seizures
Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge
Article links:
The Effect of Epilepsy Surgery on Tonic–Clonic Seizures
Patient Perspectives on Antiseizure Medication Discontinuation
Antiseizure Medication Use and Outcomes After Suspected
or Confirmed Acute Symptomatic Seizures
Association of Outpatient Follow-Up With 30-Day Readmission After Epilepsy or Seizure Discharge in Medicare Beneficiaries Aged 65 and Older
Disclosures can be found at Neurology.org.